NCT02050269View on ClinicalTrials.gov

Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study

PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Acute Circulatory Failure
Interventions
DRUG

Iohexol

Iohexol, 300 mg/mL

Trial Locations (3)

37044

Service de Réanimation Polyvalente, CHRU de Tours, Tours

45000

Hospital La SOURCE, Orléans

67000

University Hospital Strasbourg, Strasbourg

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT02050269 - Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study | Biotech Hunter | Biotech Hunter